More Details on 10X ' s Sample Profiling Trident

10X Genomics had an online event Wednesday called Xperience (as far as I could tell no Jimmy Hendrix music was used, a missed opportunity!) to lay out their development roadmap.   This largely paralleled thepresentation given at J.P. Morgan, but there were a few new bits and of course much more technical detail to whet the appetites of scientists -- and judging from a number of very positive tweets I saw today they were successful in that goal. Some of the 10X management was kind enough to walk me through the deck earlier this week as well as permission to borrow images from it, so this summary is based on that as well as watching the presentation.   While their name is 10X, the company emphasized progress on three axes: scale, resolution and access and that progress across the three different platforms. Read more »

Source: Omics! Omics! - February 26, 2021 Category: Bioinformatics Authors: Keith Robison Source Type: blogs